Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2017 - Issue
Submit an article Journal homepage
92
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

Cheong-Ju Kim1 Department of Internal Medicine, National Health Insurance System Ilsan Hospital, Koyang
,
Hyoung-Kyu Yoon2 Division of Pulmonology, Department of Internal Medicine, St Mary’s Hospital, College of Medicine, The Catholic University of Korea
,
Myung-Jae Park3 Division of Respiratory and Critical Care Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul
,
Kwang-Ha Yoo4 Department of Internal Medicine, Konkuk University School of Medicine, Gwangjin-gu
,
Ki-Suck Jung5 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Hallym University Sacred Heart Hospital, Hallym University Medical School, Anyang-si
,
Jeong-Woong Park6 Division of Pulmonary and Allergy Medicine, Gachon University Gil Medical Center, Incheon
,
Seong Yong Lim7 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine
,
Jae Jeong Shim8 Department of Internal Medicine, Korea University College of Medicine, Seoul
,
Yong Chul Lee9 Department of Internal Medicine and Research Center for Pulmonary Disorders, Chonbuk National University Medical School, Jeonbuk
,
Young-Sam Kim10 Department of Internal Medicine, Yonsei University College of Medicine
,
Yeon-Mok Oh11 Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine
,
Song Kim12 Clinical Development and Medical Affairs, Novartis Korea Ltd., Seoul
&
Chul-Gyu Yoo13 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, KoreaCorrespondence[email protected]
 show all
Pages 1589-1596 | Published online: 29 May 2017

References

  • Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease2016 Available from: http://goldcopd.org/Accessed May 5, 2016
  • HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J200628352353216611654
  • ByrneALMaraisBJMitnickCDLeccaLMarksGBTuberculosis and chronic respiratory disease: a systematic reviewInt J Infect Dis20153213814625809770
  • HassanISAl-JahdaliHHObstructive airways disease in patients with significant post-tuberculous lung scarringSaudi Med J20052671155115716047080
  • KimHYSongKSGooJMLeeJSLeeKSLimTHThoracic sequelae and complications of tuberculosisRadiographics200121483985811452057
  • RheeCKYooKHLeeJHClinical characteristics of patients with tuberculosis-destroyed lungInt J Tuberc Lung Dis2013171677523232006
  • DonohueJFFogartyCLötvallJINHANCE Study InvestigatorsOnce-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropiumAm J Respir Crit Care Med2010182215516220463178
  • KornSKerwinEAtisSAmosCOwenRLassenCINSIST study groupIndacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week studyRespir Med2011105571972621367594
  • JonesPWBarnesNVogelmeierCLawrenceDKramerBEfficacy of indacaterol in the treatment of patients with COPDPrim Care Respir J201120438038821785813
  • CopeSDonohueJFJansenJPComparative efficacy of long-acting bronchodilators for COPD: a network meta-analysisRespir Res20131410024093477
  • InghammarMEkbomAEngströmGCOPD and the risk of tuberculosis – a population-based cohort studyPLoS One201054e1013820405056
  • YakarHIGunenHPehlivanEThe role of tuberculosis in COPDInt J Chron Obstruct Pulmon Dis20171232332928176901
  • ShuCCWuHDYuMCTaiwan Anti-Mycobacteria Investigation (TAMI) Group. Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary diseaseMedicine (Baltimore)2010891536120075705
  • KimJHParkJSKimKHJeongHCKimEKLeeJHInhaled corticosteroid is associated with an increased risk of TB in patients with COPDChest201314341018102423079688
  • WillcoxPAFergusonADChronic obstructive airways disease following treated pulmonary tuberculosisRespir Med19898331951982595036
  • MenezesAMHallalPCPerez-PadillaRLatin American Project for the Investigation of Obstructive Lung Disease (PLATINO) Team. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin AmericaEur Respir J20073061180118517804445
  • YumHKParkINEffect of inhaled tiotropium on spirometric parameters in patients with tuberculous destroyed lungTuberc Respir Dis (Seoul)201477416717125368662
  • SethHDSultanSGotfriedMHRole of indacaterol, a once-daily bronchodilator, in chronic obstructive pulmonary diseaseJ Thorac Dis20135680681424409359
  • ChapmanKRRennardSIDograAOwenRLassenCKramerBINDORSE Study InvestigatorsLong-term safety and efficacy of indacaterol, a long-acting β2-agonist, in subjects with COPD: a randomized, placebo-controlled studyChest20111401687521349928
  • FeldmanGSilerTPrasadNINLIGHT 1 study group. Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week studyBMC Pulm Med2010101120211002

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.